Export 40 results:
Author Title [ Type(Desc)] Year
Filters: Author is Wolff, M  [Clear All Filters]
Journal Article
T. G. Boyce, Gruber, W. C., Coleman-Dockery, S. D., Sannella, E. C., Reed, G. W., Wolff, M., and Wright, P. F., Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children., Vaccine, vol. 18, no. 1-2, pp. 82-8, 1999.
W. H. Chen, Winokur, P. L., Edwards, K. M., Jackson, L. A., Wald, A., Walter, E. B., Noah, D. L., Wolff, M., Kotloff, K. L., Chua, J. V., Hutter, J., Stephens, I., Stapleton, J., Meier, J., Callahan, S. T., Creech, C. B., Halasa, N. B., Johnston, C., Dolor, R. J., Schmader, K. E., Woods, C. W., and Hill, H., Phase 2 Assessment of the Safety and Immunogenicity of Two Inactivated Pandemic Monovalent H1N1 Vaccines in Adults as a Component of the U.S. Pandemic Preparedness Plan in 2009, Vaccine, vol. 13, pp. 4240-4248, 2012.
M. J. McElrath, Corey, L., Montefiori, D., Wolff, M., Schwartz, D., Keefer, M., Belshe, R., Graham, B. S., Matthews, T., Wright, P., Gorse, G., Dolin, R., Berman, P., Francis, D., Duliege, A. M., Bolognesi, D., Stablein, D., Ketter, N., and Fast, P., A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group., AIDS Res Hum Retroviruses, vol. 16, no. 9, pp. 907-19, 2000.
M. J. McElrath, Corey, L., Montefiori, D., Wolff, M., Schwartz, D., Keefer, M., Belshe, R., Graham, B. S., Matthews, T., Wright, P., Gorse, G., Dolin, R., Berman, P., Francis, D., Duliege, A. M., Bolognesi, D., Stablein, D., Ketter, N., Fast, P., and Grou, theA. I. D. S. Vacci, A Phase II study of two HIV-1 envelope vaccines comparing their immunogenicity in populations at risk for acquiring HIV-1 infection, AIDS Res HumRetroviruses, vol. 16, pp. 907-19, 2000.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. E., Rouphael, N. G., Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., Phase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations, Vaccine, vol. 33, pp. 163-173, 2015.
E. Hook, Behets, F., Van Damme, K., Ravelomanana, N., Leone, P., Seña, A., Martin, D., Langley, C., McNeil, L., and Wolff, M., A Phase III Equivalence Trial of Azithromycin vs. Benzathine Penicillin for Treatment of Early Syphilis, J Infect Dis, vol. 201, pp. 1729-1735, 2010.
A. C. Seña, Wolff, M., Martin, D. H., Behets, F., Van Damme, K., Leone, P. A., Langley, C., McNeil, L., and Hook, E. W., Predictors of Serological Cure and Serofast State After Treatment in HIV-Negative Persons With Early Syphilis, Clin Infect Dis, vol. 11, pp. 1092-1099, 2011.
K. M. Holman, Wolff, M., Seña, A. C., Martin, D. H., Behets, F., Van Damme, K., Leone, P. A., McNeil, L., Gehrig, M. L., and Hook, E. W. 3rd, Rapid Plasma Reagin Titer Variation in the 2 Weeks After Syphilis Therapy, Sex Transm Dis, vol. 39, pp. 645-647, 2012.
A. C. Seña, Wolff, M., Behets, F., Van Damme, K., and , Response to Therapy Following Retreatment of Serofast Early Syphilis Patients with Benzathine Penicillin, Clin Infect Dis, vol. 56, pp. 420-422, 2013.
B. Rivoire, Groathouse, N., TerLouw, S., K Neupane, D., Ranjit, C., B Sapkota, R., Khadge, S., Kunwar, C., Macdonald, M., Hawksworth, R., Thapa, M., Hagge, D., Tibbals, M., Smith, C., Dube, T., She, D., Wolff, M., ,, Sizemore, C., and Brennan, P., Safety and Efficacy Assessment of Two New Leprosy Skin Test Antigens: Randomized Double Blind Clinical Study, PLOS Neglected Tropical Diseases, vol. 8, p. e2811, 2014.
S. E. Frey, Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., Turley, C. B., Rupp, R. E., Hill, H., Wolff, M., Noah, D. L., Ross, A. C., Cress, G., and Belshe, R. B., Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations, J Infect Dis, vol. 206, pp. 828-837, 2012.
J. J. Treanor, Wilkinson, B. E., Masseoud, F., Hu-Primmer, J., Battaglia, R., O’Brien, D., Wolff, M., Rabinovich, G., Blackwelder, W., and Katz, J. M., Safety and Immunogenicity of a Recombinant Hemagglutinin Vaccine for H5 Influenza in Humans, Vaccine, vol. 19, pp. 1732-1737, 2001.
J. J. Treanor, Wilkinson, B. E., Masseoud, F., Hu-Primmer, J., Battaglia, R., O'Brien, D., Wolff, M., Rabinovich, G., Blackwelder, W., and Katz, J. M., Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans., Vaccine, vol. 19, no. 13-14, pp. 1732-7, 2001.
S. Frey, Houghton, M., Coates, S., Abrignani, S., Chien, D., Rosa, D., Pileri, P., Ray, R., Di Bisceglie, A., Rinella, P., Hill, H., Wolff, M., Schultze, V., Han, J., Scharschmidt, B., and Belshe, R., Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted with MF59 Administered to Healthy Adults, Vaccine, vol. 28, pp. 6367-6373, 2010.
M. C. Keefer, Wolff, M., Gorse, G. J., Graham, B. S., Corey, L., Clements-Mann, M. L., Verani-Ketter, N., Erb, S., Smith, C. M., Belshe, R. B., Wagner, L. J., McElrath, M. J., Schwartz, D. H., and Fast, P., Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group., AIDS Res Hum Retroviruses, vol. 13, no. 14, pp. 1163-77, 1997.